Johannes Brägelmann

18PUBLICATIONS
134CO-AUTHORS
Molecular targetsInnate immunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 15, 2026
Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis.

|Mar 06, 2026
Lysine-11 ubiquitination drives type-I/III interferon induction by cGAS-STING and Toll-like receptors 3 and 4.

Alexis Betrancourt, M Talha Cinko, Ana Beatriz Varanda

|Dec 18, 2025
Lack of caspase 8 directs neuronal progenitor-like reprogramming and small cell lung cancer progression.

Ariadne Androulidaki, Fanyu Liu, Christina M Bebber

|Dec 08, 2025
ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer.

Lydia Meder, Charlotte I Orschel, Cyrielle L Bouchez

|Sep 19, 2025
Publisher Correction: Functional synapses between neurons and small cell lung cancer.

Vignesh Sakthivelu, Anna Schmitt, Franka Odenthal

|Sep 10, 2025
Functional synapses between neurons and small cell lung cancer.

Vignesh Sakthivelu, Anna Schmitt, Franka Odenthal

Pageof 3

Frequent Collaborators

7 joint publications

Reinhard Büttner

7 joint publications

Martin L Sos

6 joint publications

Silvia von Karstedt

6 joint publications

Filippo Beleggia